A Cancer Conundrum: Too Many Drug Trials, Too Few Patients by GINA KOLATA

This entry was posted in Health Weight Watchers and tagged Health NYT on by

Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients.

Published: August 12, 2017 at 02:00AM

from NYT Health https://ift.tt/2fBCrz7